PROVEN PROPHYLAXIS + SIMPLE, TWICE-WEEKLY DOSING SCHEDULE =
moments THEIR WAY
ADYNOVATE [Antihemophilic Factor (Recombinant), PEGylated] Important Information
Indication
ADYNOVATE, Antihemophilic Factor (Recombinant), PEGylated, is a human antihemophilic factor indicated in adolescent and adult patients (12 years and older) with hemophilia A (congenital factor VIII deficiency) for:
-On-demand treatment and control of bleeding episodes
-Routine prophylaxis to reduce the frequency of bleeding episodes
ADYNOVATE is not indicated for the treatment of von Willebrand disease.
Baxalta, Advate, and Adynovate are trademarks of Baxalta Incorporated.
Baxalta
Brand:Adynovate Generic name/category: [Antihemophilic Factor (Recombinant), Pegylated] Company: Baxalta Country/Market: USA, North America Indication(s)/Disease: hemophilia A Target: Healthcare Professional (HCP) Tagline: None Size/duration: Single-page Publication/Aired: ASH Clinical News - April 2016 See more Adynovate ads here
Adynovate